Paper709776
Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment.
Okada RD and 5 others. Circulation, 1978. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment. Papers, record 709776. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/709776
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atrial Fibrillation | Major topic |
| Digoxin | Major topic |
| Heart Failure | Major topic |
| Kidney | Major topic |
| Kidney Failure, Chronic | Major topic |
| Administration, Oral | |
| Adult | |
| Aged | |
| Dose-Response Relationship, Drug | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Tablets | |
| Time Factors |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29420067 | Organic solute transporter OSTα/β is overexpressed in nonalcoholic steatohepatitis and modulated by drugs associated with liver injury. | Am J Physiol Gastrointest Liver Physiol | 2018 | https://conductscience.org/library/papers/29420067 | PubMed |
| 28057840 | Delineating the Role of Various Factors in Renal Disposition of Digoxin through Application of Physiologically Based Kidney Model to Renal Impairment Populations. | J Pharmacol Exp Ther | 2017 | https://conductscience.org/library/papers/28057840 | PubMed |
| 7428668 | Drug interactions with digoxin. | Drugs | 1980 | https://conductscience.org/library/papers/7428668 | PubMed |
| 7202477 | Skeletal muscle digoxin concentration during digitalization and during withdrawal of digoxin treatment. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7202477 | PubMed |
| 7202476 | Skeletal muscle digoxin concentration and its relation to serum digoxin concentration and cardiac effect in healthy man. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7202476 | PubMed |
| 7120047 | The pharmacokinetics of digoxin in newborn and adult sheep. | J Pharmacokinet Biopharm | 1982 | https://conductscience.org/library/papers/7120047 | PubMed |
| 7014827 | A standard approach to compiling clinical pharmacokinetic data. | J Pharmacokinet Biopharm | 1981 | https://conductscience.org/library/papers/7014827 | PubMed |
| 6988136 | Clinical pharmacokinetics of digoxin 1980. | Clin Pharmacokinet | 1980 | https://conductscience.org/library/papers/6988136 | PubMed |
| 6754209 | Disease-related alterations in cardiac glycoside disposition. | Clin Pharmacokinet | 1982 | https://conductscience.org/library/papers/6754209 | PubMed |
| 6342898 | Clinical pharmacokinetics of cardiac glycosides in patients with renal dysfunction. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6342898 | PubMed |
| 3882303 | Comparison of drug dosing methods. | Clin Pharmacokinet | 1985 | https://conductscience.org/library/papers/3882303 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/709776
GET https://conductscience.org/api/papers/v1/709776/authors